drugset / Trial / NCT01799694

Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO)

NCT01799694 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the feasibility and security of the autologous e-ASC for the urinary incontinence after a radical prostate cancer surgery

Timeline

Start
2011-07
Primary completion
2013-02
Completion
2013-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose derived stem cells Cell therapy — Intramuscular

Indications

No indication recorded.